Project Leader
European Medicines Agency
Dr. Hans-Georg Eichler
Deputy Project Leader
AstraZeneca
Dr. Solange Rohou
Coordinator
Lygature
Dr. André Broekmans
Funding
Within the ADAPT SMART project, EU funding is only used to fund activities of non-EFPIA partners. EFPIA companies do not receive EU funding. No cash contributions are made from EFPIA companies to EU or Member State public sector entities.
Cash contributions from EFPIA partners are made to two non-governmental organisations, MIT/NEWDIGS and TI PHARMA, to support limited and specific activities (scenario analysis work and IT infrastructure respectively).
The ADAPT SMART Structure
International Advisory Board
| Stakeholder Group | Region | Organisation | IAB Member |
|---|---|---|---|
| Patients | US | NHC | Boutin, Marc |
| Payers | US | BlueCrossBlueShield | Haywood, Trent |
| Other | World | WHO | Hill, Sue |
| Media | EU | Financial Times | Jack, Andrew |
| Regulators | US | FDA | Jarow, Jonathan |
| Patients | EU | EPF | Johnstone, Robert |
| Regulators | JP | PMDA | Kondo, Tatsuya |
| HTA bodies | CAN | CADTH | O’Rourke, Brain (chair) |
| HTA bodies | US | ICER | Pearson, Steve |
| Investors | EU | Robeco | Vanacker, Stijn |
| ADAPT SMART | EU | EMA | Eichler, Hans-Georg |
| ADAPT SMART | EU | AstraZeneca | Rohou, Solange |
| ADAPT SMART | EU | Lygature | Broekmans, André |
